Loading
Total declarations
Company
▲ Purchases (16 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Jul 2011 for NeurogesX Inc, €33k.
Insider track record
Disclosed buys
16
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
16
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael Markels: trading record in brief
All filings by Michael Markels on record concern NeurogesX Inc. The record holds 19 filings, for trades running from 19 November 2007 to 1 September 2012.
Purchases make up the whole of the open-market record (16 purchases, €35k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants.
In size, the median ticket on the buying side is €1,117.
Most recently, on 19 September 2012, the filings show a share grant worth €2,997 in NeurogesX Inc. The last insider purchase was made public on 20 August 2010, 5,909 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael Markels
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
29,069 shares@ US$1.65Common StockSEC:0001181431-11-042505:0
2,500 shares@ US$5.75Common StockSEC:0001181431-10-042853:0
Canonical exit: 17 Nov 2010 (T+90)
96 shares@ US$1.50Common StockSEC:0001181431-08-066870:0
Canonical exit: 9 Mar 2009 (T+90)
1,000 shares@ US$1.51Common StockSEC:0001181431-08-066124:0
Canonical exit: 4 Mar 2009 (T+90)
1,000 shares@ US$1.80Common StockSEC:0001181431-08-066124:1
Canonical exit: 8 Mar 2009 (T+90)
1,700 shares@ US$1.51Common StockSEC:0001181431-08-063990:0
Canonical exit: 19 Feb 2009 (T+90)
499 shares@ US$1.50Common StockSEC:0001181431-08-063243:2
Canonical exit: 18 Feb 2009 (T+90)
699 shares@ US$1.50Common StockSEC:0001181431-08-063243:0
Canonical exit: 16 Feb 2009 (T+90)
502 shares@ US$1.50Common StockSEC:0001181431-08-063243:1
Canonical exit: 17 Feb 2009 (T+90)
100 shares@ US$1.54Common StockSEC:0001181431-08-061842:0
Canonical exit: 10 Feb 2009 (T+90)
800 shares@ US$1.73Common StockSEC:0001181431-08-061842:1
Canonical exit: 10 Feb 2009 (T+90)
800 shares@ US$1.75Common StockSEC:0001181431-08-061842:2
Canonical exit: 10 Feb 2009 (T+90)
1,450 shares@ US$1.55Common StockSEC:0001181431-08-061842:3
Canonical exit: 11 Feb 2009 (T+90)
100 shares@ US$6.35Common StockSEC:0001181431-07-071177:0
Canonical exit: 17 Feb 2008 (T+90)
200 shares@ US$6.36Common StockSEC:0001181431-07-071177:1
Canonical exit: 17 Feb 2008 (T+90)
1,000 shares@ US$6.42Common StockSEC:0001181431-07-071177:2
Canonical exit: 18 Feb 2008 (T+90)
1,700 shares@ US$6.48Common StockSEC:0001181431-07-071177:3
Canonical exit: 18 Feb 2008 (T+90)
17 of 17 declarations
